Daewoong-Bio Inc.

Company Details

  • Operational Address : 12, Bongeunsa-ro 114-gil, Gangnam-gu, Seoul, South Korea
  • Business Type : Manufacturer, Trading Company, Buying Office
  • Location : Seoul, South Korea
  • Year Established : 1983
  • Main Markets : Eastern Asia 46.00% Domestic Market 38.00% Western Europe 9.00%
  • Main Products : UDCA, Meropenem,Lansoprazole,Rabeprazole, Ceftriaxone
  • Links : Korea Chemicals, Korea Pharmaceuticals, Korea Immune Function Agents,
  • Company Introduction

    Daewoong Bio Inc., an independent affiliate of the Daewoong Group based in Seoul, South Korea, was company founded in 1983. Daewoong Bio produces cGMP complaint world-class products under quality guarantee systems. As a key manufacturer, Daewoong Bio provides APIs for global distribution and to multinational corporations developing original products. Daewoong Bio is also a full-service pharmaceutical company that utilizes our internal R&D, production facilities, and experienced marketing force with external global networks. Daewoong Bio is specialized to produce both world-class antibiotic APIs and general APIs.

    Company Information

  • Contact Person : Ms. Heeran Kim
  • Telephone :
  • Website : http://www.daewoongchemical.co.kr/
  • Company Product

      Cefaclor